M. De Alvarado

Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with <scp>NICE</scp> guidelines and <scp>ACOG</scp> recommendations

N. O’Gorman, D. Wright, Liona C. Poon et al. · Ultrasound in Obstetrics and Gynecology · 2017 · 364 citations · Full text

Medicine, Maternal Health, Obstetrics +17

Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia

D. Wright, Liona C. Poon, Daniel L. Rolnik et al. · American Journal of Obstetrics and Gynecology · 2017 · 167 citations · Full text

Medicine, Maternal Health, Obstetrics +11

Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit

D. Wright, Daniel L. Rolnik, Argyro Syngelaki et al. · American Journal of Obstetrics and Gynecology · 2018 · 116 citations · Full text

Medicine, Maternal Health, Obstetrics +17

Prediction of pre‐eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks' gestation: data from <scp>EVENTS</scp> trial

Z. Benkő, Alan Wright, Anoop Rehal et al. · Ultrasound in Obstetrics and Gynecology · 2020 · 46 citations · Full text

Medicine, Maternal Health, Obstetrics +17

<scp>STATIN</scp> trial: predictive performance of competing‐risks model in screening for pre‐eclampsia at 35–37 weeks' gestation

Moritz Döbert, Alan Wright, Anna-Nektaria Varouxaki et al. · Ultrasound in Obstetrics and Gynecology · 2021 · 31 citations

Medicine, Maternal Health, Obstetrics +17